Study to evaluate the efficacy of Nishalauha and Vasaadi Kwatha in Pandu Roga
Phase 4
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2024/06/068815
- Lead Sponsor
- Principal Rajiv Gandhi Government Ayurvedic College and Hospital Paprola District Kangra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients presenting with signs and symptoms of pandu roga having haemoglobin 8-12gm% in males and 8-11gm% in females.
Exclusion Criteria
patients suffering from chronic respiratory cardiac renal disorders, Diabetes mellitus, pregnant and lactating mothers , CA, TB
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Nishalauha and Vasaadi Kwatha's efficacy in iron deficiency anemia?
How does the combination of Nishalauha and Vasaadi Kwatha compare to standard iron supplementation therapies for D509 anemia?
Are there specific biomarkers that correlate with improved hemoglobin levels in Pandu Roga patients treated with Nishalauha and Vasaadi Kwatha?
What are the potential adverse events associated with Nishalauha and Vasaadi Kwatha treatment in anemic patients?
What other Ayurvedic compounds or combination therapies are being investigated for iron deficiency anemia alongside Nishalauha and Vasaadi Kwatha?